Clinical trial Recruiting at 1 site Observational Ages 18 to 44 Women only

Effective Communication in VBAC Counseling

Official title: ComPARE: Effective COMmunication in Perinatal cARE Cross-sectional Study

Run by IRCCS San Raffaele · NCT07919145 · Data updated 2026-11-12

This study tests how clearly doctors and midwives explain VBAC options during prenatal visits and whether patients feel understood.

Quick facts

Study typeObservational
Ages18 Years to 44 Years
SexWomen only
Enrollment50 (estimated)
SponsorIRCCS San Raffaele
Academic / other
Locations1 site (Milan, MI)
StatusRecruiting
StartedSeptember 16, 2026
Main results expectedSeptember 16, 2029
Study endsSeptember 16, 2031
Registry record updatedNovember 5, 2026
Trial IDNCT07919145 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Pregnant individuals with a singleton pregnancy, 33-37 weeks gestation, aged 18-44, with a history of at least one prior cesarean delivery, planning delivery at IRCCS Ospedale San Raffaele, able to communicate in Italian and consent to audio recording.

Probably not a fit

Individuals not considering VBAC, not meeting gestational age or prior cesarean criteria, or unwilling to have audio-recorded consultations may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

ComPARE is a cross-sectional observational study that analyzes the clarity and usefulness of communication between healthcare professionals and pregnant people considering VBAC. The project uses the TouCAN Codebook to identify potential misunderstandings in routine VBAC consultations. It involves 50 pregnant individuals and 12 clinicians (6 obstetricians/gynecologists and 6 VBAC-expert midwives) at IRCCS Ospedale San Raffaele in Italy, over a 5-year period with 2 years of enrollment. The goal is to see if communication misunderstandings relate to patients’ perceived quality of the consultation and to improve shared decision-making in perinatal care.

Why it matters

Potential benefit: Better understanding of communication gaps could lead to clearer counseling and more informed VBAC decisions.

How similar studies have gone: Previous work applying structured communication analyses in perinatal care suggests potential to identify actionable misunderstandings, though this exact approach in VBAC counselling is relatively novel in this setting.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria

1. Singleton pregnancy.
2. Gestational age between 33 and 37 weeks at the time of the prenatal consultation.
3. Maternal age between 18 and 44 years, inclusive.
4. Ability to communicate in Italian and understand the study procedures.
5. History of at least one previous caesarean delivery.
6. Planned delivery at IRCCS Ospedale San Raffaele.
7. Provision of written informed consent for study participation and audio recording of the consultation.

Exclusion Criteria

1. Multiple pregnancy.
2. Obstetric emergencies or urgent clinical conditions requiring immediate medical intervention that would prevent the planned prenatal counselling consultation.
3. Inability to provide valid informed consent.
4. Refusal of audio recording of the consultation.
5. Clinical or logistical circumstances preventing participation in the interview following the consultation.

Where it's running

  • IRCCS Ospedale San Raffaele
    Milan, Mi, Italy
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.